Kyle Parcella - Concepedia

Author

Kyle Parcella

Also Known As

Kyle E. Parcella, Kyle Parcella, Parcella, Kyle

Publications

164

Citations

H-Index

Concepts

All Affiliations

Kyle Parcella is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and hepatitis c.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	31
2	Natural Sciences	1	1	31
3	Biochemistry	1	1	31
4	Immunology	1	1	31
5	Molecular Biology	1	1	31

Kyle Parcella

Publications

129

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies Kap‐Sun Yeung, Brett R. Beno, Kyle Parcella, Journal of Medicinal Chemistry Hepatitis C VirusImmunologyMolecular BiologyNs5b ReplicaseAntiviral Drug	2017	31
Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor Kyle Parcella, Kyle J. Eastman, Kap‐Sun Yeung, ACS Medicinal Chemistry Letters	2017	25
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold Eric P. Gillis, Kyle Parcella, Michael Bowsher, Journal of Medicinal Chemistry	2023	22
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase Kyle J. Eastman, Kyle Parcella, Kap‐Sun Yeung, MedChemComm	2017	18
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor Kyle Parcella, Tao Wang, Kyle J. Eastman, ACS Medicinal Chemistry Letters	2022	12
Antiviral Properties of HIV-1 Capsid Inhibitor GSK878 Chunfu Wang, Haichang Huang, Kirsten Mallon, Antimicrobial Agents and Chemotherapy	2023	11
Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitors Xiaoliang Zhuo, Yingzi Wang, Kap‐Sun Yeung, Xenobiotica	2017	10

Page 1